Quality of Life in Head and Neck Cancer Patients After Treatment With High-Dose Radiotherapy Alone or in Combination With Cetuximab

Abstract

The addition of cetuximab to radiotherapy significantly improved locoregional control and increased overall survival without adversely affecting QoL.